eFFECTOR Therapeutics (EFTR) Institutional Ownership $0.0004 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for eFFECTOR Therapeutics (NASDAQ:EFTR)CurrentInstitutional OwnershipPercentage57.67%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.91MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$88.94M Get EFTR Insider Trade Alerts Want to know when executives and insiders are buying or selling eFFECTOR Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EFTR Institutional Buying and Selling by Quarter Ad Porter & CompanyWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. eFFECTOR Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2024Blackstone Inc.52,343$753K0.0%-96.0%1.419% 5/14/2024StemPoint Capital LP132,793$1.91M0.5%N/A3.599% 5/3/2024Carlyle Group Inc.192,884$2.72M0.2%-96.0%5.227% 11/13/2023Column Group LLC4,026,224$2.42M1.6%-6.6%9.496% 11/2/2023 Sonora Investment Management Group LLC125,000$75K0.0%N/A0.295% 6/5/2023EP Wealth Advisors LLC17,607$1.65M0.0%N/A0.042% 5/5/2023Carlyle Group Inc.4,822,114$1.69M0.1%N/A11.373% 8/16/2022Callan Capital LLC20,000$28K0.0%N/A0.048% 8/2/2022Resolute Financial LLC30,000$43K0.0%N/A0.072% 8/1/2022Parallel Advisors LLC1,693,559$2.41M0.1%+150.0%4.092% 4/28/2022Parallel Advisors LLC677,452$2.74M0.1%N/A1.637% 2/15/2022SR One Capital Management LP6,822,114$56.49M31.9%N/A16.898% 2/9/2022Alps Advisors Inc.51,942$430K0.0%N/A0.129% 2/3/2022OUP Management Co. LLC1,025,697$8.49M3.8%N/A2.541% 11/16/2021Verition Fund Management LLC24,667$347K0.0%N/A0.061% 11/15/2021Abingworth LLP4,822,114$67.03M15.2%N/A11.964% 11/15/2021Sectoral Asset Management Inc2,882,744$40.50M3.4%N/A7.153% (Data available from 1/1/2016 forward) EFTR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EFTR shares? During the previous two years, the following institutional investors and hedge funds held shares of eFFECTOR Therapeutics shares: Carlyle Group Inc. ($2.72M), Column Group LLC ($2.42M), StemPoint Capital LP ($1.91M), EP Wealth Advisors LLC ($1.65M), and Blackstone Inc. ($753K), Sonora Investment Management Group LLC ($75K).Learn more on EFTR's institutional investors. What percentage of eFFECTOR Therapeutics stock is owned by institutional investors? 57.67% of eFFECTOR Therapeutics stock is owned by institutional investors. Learn more on EFTR's institutional investor holdings. Which institutional investors have been buying eFFECTOR Therapeutics stock? The following institutional investors have purchased eFFECTOR Therapeutics stock in the last 24 months: Carlyle Group Inc. ($4.82M), StemPoint Capital LP ($132.79K), Sonora Investment Management Group LLC ($125K), and EP Wealth Advisors LLC ($17.61K). How much institutional buying is happening at eFFECTOR Therapeutics? Institutional investors have bought a total of 5,097,514 shares in the last 24 months. This purchase volume represents approximately $46.46M in transactions. Which eFFECTOR Therapeutics major shareholders have been selling company stock? The following institutional investors have sold eFFECTOR Therapeutics stock in the last 24 months: Carlyle Group Inc. ($4.63M), Blackstone Inc. ($1.26M), and Column Group LLC ($283.11K). How much institutional selling is happening at eFFECTOR Therapeutics? Institutional investors have sold a total of 6,168,579 shares in the last 24 months. This volume of shares sold represents approximately $88.94M in transactions. Related Companies Evelo Biosciences Major Shareholders Alvotech Major Shareholders Pharvaris Major Shareholders PowerUp Acquisition Major Shareholders Mondee Major Shareholders This page (NASDAQ:EFTR) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eFFECTOR Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share eFFECTOR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
